By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Colby Pharmaceutical 

1095 Colby Avenue
Suite C
Menlo Park  California  94025-2334  U.S.A.
Phone: 650-333-3150 Fax: 650-323-6215



Drug Discovery

Company News
Colby Pharmaceutical and MannKind Corporation (MNKD) Sign License and Joint Development Agreement to Develop and Commercialize Cancer Immunotherapy Products 11/13/2012 9:32:17 AM
Colby Pharmaceutical Announces SBIR Award for JunD Oncoprotein-Androgen Receptor (AR) Interaction Inhibitor Drugs in Novel Prostate Cancer Therapy 10/1/2012 10:08:12 AM
Colby Pharmaceutical Acquires Othera Pharmaceuticals 9/19/2012 10:08:08 AM
Colby Pharmaceutical Announces Publication of JVRS-100 use as Potent Immune Activating Adjuvant in Combination with H5N1 Influenza Vaccine 1/9/2012 6:05:23 AM
Juvaris BioTherapeutics Announces License to Colby Pharmaceutical for JVRS-100 and CLDC (Cationic Lipid-DNA Complex) Platform for Human Health 9/9/2011 10:40:05 AM
Adamis Completes Acquisition of Prostate Drug Candidates from Colby Pharmaceutical 10/19/2010 11:23:36 AM
Adamis Signs Agreement With Colby Pharmaceutical to Acquire Prostate Cancer Drug Candidates 2/25/2010 10:47:27 AM